Novel biomarkers predict benefit with immunotherapy in metastatic breast cancer

(European Society for Medical Oncology) Two novel biomarkers have been found to correlate with improved outcomes with immunotherapy in metastatic breast cancer and may help to identify the patients most likely to benefit from this treatment, according to exploratory studies reported at the ESMO Breast Cancer Virtual Meeting 2020.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news